NASDAQ · Analyst Forecast

Boundless Bio, Inc. (BOLD) Stock Forecast & Price Target

$2.41 NASDAQ: BOLD Market Cap $56.90M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 16, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Boundless Bio, Inc. (BOLD), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Boundless Bio, Inc., the average estimate for 2030 earnings per share is −$1.40; 2 analysts contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$0$0$02
2026$0$0$01
2027$0$0$01
2028$8.40M$8.40M$8.40M1
2029$0$0$01
2030$0$0$01

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$2.47−$2.47−$2.472
2026−$1.71−$1.71−$1.711
2027−$0.75−$0.75−$0.751
2028−$1.56−$1.56−$1.561
2029−$1.34−$1.34−$1.341
2030−$1.40−$1.40−$1.401

Boundless Bio, Inc. (BOLD) forecast — frequently asked questions

What are analysts forecasting for Boundless Bio, Inc.'s earnings?

The average analyst estimate for Boundless Bio, Inc. (BOLD) earnings per share in 2030 is -1.40, with individual estimates between -1.40 and -1.40.

How much revenue is Boundless Bio, Inc. expected to make?

Analysts forecast Boundless Bio, Inc. (BOLD) revenue of $0 in 2030, based on 1 published estimates.

How many analysts cover BOLD?

2 analysts contribute estimates for Boundless Bio, Inc. (BOLD). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.